vTv Therapeutics Inc. (VTVT) Financials

$14.79

$0.12 (0.82%)
Last update: 04:00 PM EST
Day's range
$14.79
Day's range
$15.16
$20M$20M$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420240%0%-500%-500%-1000%-1000%-1500%-1500%-2000%-2000%-2500%-2500%Profit Margin
Profit Margin
Revenue
Earnings

VTVT Income statement / Annual

Last year (2024), vTv Therapeutics Inc.'s total revenue was $1.02 M, and the percentage change from the previous year is not available. In 2024, vTv Therapeutics Inc.'s net income was -$18.46 M. See vTv Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $1.02 M $0.00 $2.02 M $4.01 M $6.41 M $2.76 M $12.43 M $291.00 K $634.00 K $519.00 K
Cost of Revenue $89.00 K $13.60 M $92.00 K $89.00 K $11.02 M $15.12 M $23.04 M $39.64 M $45.75 M $29.58 M
Gross Profit $928.00 K -$13.60 M $1.93 M $3.92 M -$4.60 M -$12.36 M -$10.60 M -$39.35 M -$45.11 M -$29.07 M
Gross Profit Ratio 0.91 0 0.95 0.98 -0.72 -4.47 -0.85 -135.22 -71.16 -56
Research and Development Expenses $11.55 M $13.60 M $12.36 M $13.32 M $11.02 M $15.12 M $23.04 M $39.64 M $45.75 M $29.58 M
General & Administrative Expenses $13.65 M $11.91 M $12.20 M $12.34 M $7.25 M $8.54 M $9.22 M $11.33 M $9.91 M $9.08 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.65 M $11.91 M $12.20 M $12.34 M $7.25 M $8.54 M $9.22 M $11.33 M $9.91 M $9.08 M
Other Expenses $0.00 -$13.51 M -$2.67 M $4.06 M -$270.00 K $828.00 K -$592.00 K -$190.00 K -$22.00 K -$2.97 M
Operating Expenses $25.20 M $25.41 M $24.56 M $25.67 M $18.27 M $23.66 M $32.26 M $50.97 M $55.65 M $38.66 M
Cost And Expenses $25.20 M $25.50 M $24.56 M $25.67 M $18.27 M $23.66 M $32.26 M $50.97 M $55.65 M $38.66 M
Interest Income $1.57 M $472.00 K $352.00 K $1.00 K $12.00 K $53.00 K $61.00 K $117.00 K $87.00 K $0.00
Interest Expense $0.00 $13.00 K $15.00 K $12.00 K $692.00 K $1.83 M $3.29 M $3.09 M $398.00 K $1.74 M
Depreciation & Amortization $89.00 K $90.00 K $92.00 K $89.00 K $94.00 K $39.00 K $218.00 K $197.00 K $265.00 K $501.00 K
EBITDA -$22.52 M -$25.41 M -$24.77 M -$17.52 M -$12.02 M -$19.97 M -$20.14 M -$50.56 M -$54.69 M -$38.87 M
EBITDA Ratio -22.14 0 -12.27 -4.37 -1.87 -7.23 -1.62 -173.74 -86.26 -74.9
Operating Income Ratio -23.78 0 -11.17 -5.41 -1.85 -7.56 -1.59 -174.16 -86.78 -73.49
Total Other Income/Expenses Net $1.58 M -$464.00 K -$2.33 M $4.05 M -$950.00 K -$946.00 K -$3.82 M -$3.17 M -$333.00 K -$2.97 M
Income Before Tax -$22.61 M -$25.97 M -$24.87 M -$17.62 M -$12.80 M -$21.84 M -$23.65 M -$53.85 M -$55.35 M -$41.11 M
Income Before Tax Ratio -22.23 0 -12.33 -4.4 -2 -7.9 -1.9 -185.04 -87.31 -79.2
Income Tax Expense $100.00 K $0.00 $200.00 K $115.00 K -$3.98 M $100.00 K $200.00 K $800.00 K -$39.00 M -$14.11 M
Net Income -$18.46 M -$20.25 M -$25.07 M -$17.73 M -$8.83 M -$21.94 M -$7.91 M -$16.14 M -$16.35 M -$27.50 M
Net Income Ratio -18.15 0 -12.42 -4.43 -1.38 -7.94 -0.64 -55.48 -25.79 -52.98
EPS -3.2 -9.71 -13.06 -11.32 -7.49 -28.97 -25.42 -66.62 -68.52 -132.9
EPS Diluted -3.2 -9.71 -13.06 -11.32 -7.49 -28.97 -25.42 -66.62 -68.52 -132.9
Weighted Average Shares Out $5.77 M $2.08 M $1.92 M $1.57 M $1.18 M $757.30 K $311.23 K $242.33 K $238.64 K $206.91 K
Weighted Average Shares Out Diluted $5.77 M $2.08 M $1.92 M $1.57 M $1.18 M $757.30 K $311.23 K $242.33 K $238.64 K $206.91 K
Link